Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Biochemistry,Physiology
Link
http://link.springer.com/content/pdf/10.1007/s10456-008-9127-z.pdf
Reference51 articles.
1. Gasparini G, Longo R, Toi M, Ferrara N (2005) Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat Clin Pract Oncol 2:562–577. doi: 10.1038/ncponc0342
2. Annex BH, Simons M (2005) Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. Cardiovasc Res 65:649–655. doi: 10.1016/j.cardiores.2004.09.004
3. Patel ZS, Mikos AG (2004) Angiogenesis with biomaterial-based drug- and cell-delivery systems. J Biomater Sci Polym Ed 15:701–726. doi: 10.1163/156856204774196117
4. Ratner BD (2002) Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Release 78:211–218. doi: 10.1016/S0168-3659(01)00502-8
5. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319. doi: 10.1016/S0092-8674(00)80209-3
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role of the Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Vascular Diseases: A Therapeutic Approach;Angiology;2024-01-03
2. Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19;Research and Practice in Thrombosis and Haemostasis;2023-02
3. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction;Journal of Thrombosis and Haemostasis;2022-10
4. Modified Qing’ e Pills exerts anti-osteoporosis effects and prevents bone loss by enhancing type H blood vessel formation;Frontiers in Endocrinology;2022-09-06
5. Angiotensin II Induces Aortic Rupture and Dissection in Osteoprotegerin‐Deficient Mice;Journal of the American Heart Association;2022-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3